COVID-19 Vaccine Uptake: Awareness Perception and Determinants of its Choice in a Semi-Urban Community in South-South Nigeria
DOI:
https://doi.org/10.60787/njgp.v22i1.204Keywords:
COVID-19, Awareness, Determinants, Perception, Vaccine, OkadaAbstract
Aim: The aim of this study is to assess the awareness, perception and determinants of choice of Covid-19 vaccine in a semi-urban community.
Methodology: A cross-sectional analytical study was carried out among 323 residents of Okada Community, Edo state. Respondents were selected by cluster sampling technique. Okada has two wards (West and East) and Okada West was selected by simple random technique using computer generated random numbers. Enumeration area map of the selected ward was obtained and two of the three enumeration areas were selected using simple random sampling. Each of the two enumeration area formed a cluster and all the households in each of the selected clusters were listed. Structured, Pre tested, interviewed administered questionnaire was the tool used for data collection. Data was analyzed using IBM SPSS version 21.0 and level of significance was set at P < 0.05.
Results: A total of 323 respondents participated in the study. Majority, 218(67.5%) of respondents believed in COVID-19 existence, 291(90.1%) were aware of the COVID-19 vaccine availability, 97(30.0%) believed COVID-19 vaccine was a biological weapon and 173(53.2%) were unwilling to take the vaccine however, 221(68.4%) of respondents were willing to take the vaccine if proven safe and effective.
Conclusion: This study revealed the unwillingness of respondents to receive COVID-19 vaccine due to fear of death despite having good knowledge and perception on the COVID-19 vaccine. Government should increase awareness and health educates the people about the safety of covid-19 vaccine if COVID-19 is to be eradicated through vaccination.
Downloads
References
World Health Organisation (WHO). Impact of COVID-19 on Peoples Livelihoods, their Health and our Food systems; 2020. Available @ https://www.who.int. Accessed on 10:3:2021.
Ibukun CO, Adebayo AA. Household food security and the COVID-19 pandemic in Nigeria. Afr Dev Rev. 2021;33:7587.
Ojo TO, Ojo AO, Ojo OE, Akinwalere BO, Akinwumi AF. Determinants of COVID-19 vaccine uptake among Nigerians: Evidence from a Cross-Sectional National Survey. Arch Public Health. 2023, 26;81(1):95-120. doi: 10.1186/s13690-023-01107-1.
World Statistics Today on Covid-19. Coronavirus cases: Statistic and chart; 2020. Available @ https://www.worldometers.info. Accessed on 10 June, 2024.
Nigeria Centre For Disease Control And Prevention (NCDC). An update of COVID-19 outbreak in Nigeria for Week 46. Available @ https://ncdc.gov.ng/diseases/sitreps/. Accessed on 14 July, 2024.
Muhammad A.S, Suliman K., Abeer k., and Nadir B., Rabeea S. COVID-19 Infection: Origin, Transmission and Characteristics of human corona viruses. Journal of Advanced Research. 2020; 24: 91-98.
Thomas G. Lombardo. Coronavirus and COVID-19: what you should know. Journal of Advanced Research. 2020; 30:57-60.
Nigerian Centre for disease control. Clinical Management of COVID-19: Drugs with Potential Benefits in the Treatment of COVID-19; 2020. Available @ https://www. covid19.ncdc.gov. Accessed on 12 May, 2024.
Gallegos A. WHO Declares Public Health Emergency for Novel Coronavirus; 2020. Available @ https://www.medscape.com/viewarticle/924596. Accessed on 14 June, 2024.
Akinsunmade OM, Ogunyemi AO, Isikekpei BC, Maduafokwa BA, Otokpa E, Okerinde SS. Perceptions and Uptake of COVID-19 Vaccines amongst Undergraduate Students in a Tertiary Institution in Lagos State. Nigerian Postgraduate Medical Journal, 2023; 30(2): 104-109. DOI: 10.4103/npmj.npmj_332_22.
Food and Drug Administration. FDA Approves First Treatment for COVID-19; 2020. Available @ https: //www.fda.gov/new-events/press-announcements/fda-approves-first -treatment-covid-19. Accessed on 10 June, 2024.
National Health Scheme. Coronavirus (COVID-19) Disease Prevention Protocols; 2020. Available @ https://www.nhs.uk. Accessed on 10 June, 2024.
The Royal Pharmaceutical Society. No Significant Efficacy between courses of remdesivir in patients with severe COVID-19. The Pharmaceutical Journal. 2020; 304(7938):304-54.
United States (US) National Library of Medicine. Clinical Trials with Ivermectin in Adults with Severe COVID-19, (2020). Available @ https://www.clinicaltrials.gov.Accessed on 10 June, 2024.
World Health Organisation Africa: COVID-19 vaccines shipped by COVAX arrive in Nigeria; 2020. Available @ www.afro.who.int. Accessed on 10 June, 2024.
African Centre for Disease Control. Statement to African Union Member States on the AstraZeneca COVID-19 Vaccine to the continent and concerns about adverse event reports coming from Europe; 2021. Available @ https://www.africacdc.org. Accessed on 10 June, 2024.
Babatope T, Ilyenkova V, Marais D. COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria. Bull Natl Res Cent. 2023; 47(1): 45-67. doi: 10.1186/s42269-023-01017-w.
Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo, O, et al. COVID-19 Vaccine Acceptance and Hesitancy in Low- and Middle-Income Countries. Nat. Med.2021; 27: 13851394.
Grossman VA. The COVID-19 Vaccine: Why the Hesitancy? J. Radiol. Nurs.2021; 40: 116119.
Iliyasu Z, Umar AA, Abdullahi HM, Kwaku AA, Amole TG, Tsiga-Ahmed FI, Garba RM, Salihu HM, Aliyu MH. They Have Produced a Vaccine, but We Doubt If COVID-19 Exists: Correlates of COVID-19 Vaccine Acceptability among Adults in Kano, Nigeria. Hum. Vaccines Immunother.2021, 17, 40574064.
Mudenda S, Hikaambo CN, Daka V, Chileshe M, Mfune RL, Kampamba M, Kasanga M, Phiri M, Mufwambi W, Banda M, et al. Prevalence and Factors Associated with COVID-19 Vaccine Acceptance in Zambia: A Web-Based Cross-Sectional Study. Pan Afr. Med. J.2022; 41: 112-32.
Ackah BB.B, Woo M, Stallwood L, Fazal ZA, Okpani A, Ukah UV, Adu PA. COVID-19 Vaccine Hesitancy in Africa: A Scoping Review. Glob. Health Res. Policy.2022, 7, 21-56.
Ehis B, Esene H, Erah FO, Sule Z, Agbon-ojeme G. Covid-19 Safety Protocols And Guidelines: Awareness Perception And Factors Affecting Compliance Among Health Workers In Southern Nigeria. International Journal of Emerging Technologies and Innovative Research. 2024; 11 (7): 654-673.
Reuben RC, Danladi M, Seleh DA, Ejembi PE. Knowledge, Attitudes and Practices towards COVID-19: An Epidemiological survey in North Central Nigeria. Journal of community Health. 2020; 7:1-4.
Mohammed AAO, Elhassan EM, Malik EM. Knowledge, Attitude and Practice of Sudanese people towards covid-19: An online Survey. BMC Public Health. 2021; 21:274.
Ehis SB, Omoti EA. Covid-19 Pandemic: Save Humanity Through Good Leadership And Solidarity To Defeat The Coronavirus. Annals of Medical and Surgical Practice. 2020; 5: 7-14.
Gambo S, Shem W. Social Media and the Spread of COVID-19 Conspiracy Theories in Nigeria. Journal of Ideas in Health. 2021; 4: 432-437.
Adejumo OA, Ogundele OA, Madubuko CR, Oluwafemi RO, Okoye OC, Okonkwo KC, et al. Perceptions of the COVID-19 Vaccine and Willingness to Receive Vaccination among Health Workers in Nigeria. Public Health and Research Perspectives. 2021; 12: 236-243.
Wake AD. The Willingness to Receive COVID-19 Vaccine and Its Associated Factors: Vaccination Refusal Could Prolong the War of This PandemicA Systematic Review. Risk Management and Healthcare Policy. 2021; 14: 2609-2623.
Kamal AHM, Sarkar T, Khan MM, Roy SK, Khan SH, Hasan SMM, et al. Factors Affecting Willingness to Receive COVID-19 Vaccine among Adults: A Cross-Sectional Study in Bangladesh. Journal of Health Management. 2021; 25: 414-423.
Berihun G, Walle Z, Teshome D, Berhanu L, Derso M. COVID-19 Vaccine Acceptance and Associated Factors among College Students in Dessie City, Northeastern Ethiopia. Journal of Multidisciplinary Healthcare. 2022; 15: 1735-1746.
Alqudeimat Y, Alenezi D, AlHajri B, Alfouzan H, Almokhaizeem Z, Altamimi S, Almansouri W, Alzalzalah S, Ziyab AH. Acceptance of a COVID-19 Vaccine and Its Related Determinants among the General Adult Population in Kuwait. Med. Princ. Pract.2021; 30: 262271
Williams L, Gallant AJ, Rasmussen S, Brown Nicholls LA, Cogan N, Deakin K, Young D, Flowers P. Towards Intervention Development to Increase the Uptake of COVID-19 Vaccination among Those at High Risk: Outlining Evidence-Based and Theoretically Informed Future Intervention Content. Br. J. Health Psychol.2020; 25: 10391054.
Ba MF, Faye A, Kane B, Diallo AI, Junot A, Gaye I, Bonnet E, Ridde V. Factors Associated with COVID-19 Vaccine Hesitancy in Senegal: A Mixed Study. Hum. Vaccines Immunother.2022; 18: 2060-120.
Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. Challenges in Ensuring Global Access to COVID-19 Vaccines: Production, Affordability, Allocation, and Deployment. Lancet2021; 397: 10231034.
Loomba S, Figueiredo A, Piatek SJ, Graaf K, Larson HJ. Measuring the Impact of COVID-19 Vaccine Misinformation on Vaccination Intent in the UK and USA. Nat. Hum. Behav.2021; 5: 337348.
Paschal C, Amakiri J, Chukwuebuka O, Chidimma FC. Willingness to Accept a Potential COVID-19 Vaccine in Nigeria. American Journal of Medical Sciences and Medicine. 2021; 9:1-21.
Huynh G, Nguyen T.V, Nguyen D.D, Lam Q.M, Pham T.N and Nguyen H.T. Knowledge about COVID-19, Beliefs and Vaccination Acceptance against COVID-19 among High-Risk People in Ho Chi Minh City, Vietnam. Infection and Drug Resistance. 2021; 14:1773-1780.
Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Frontiers Public Health. 2020; 8:381-421.
Published
Issue
Section
License
Copyright (c) 2024 Nigerian Journal of General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
